Sec. 2. Promotional materials for drugs
95 words·~1 min read·
/bill/115/s/3420/is/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
In enforcing section 303(g) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 333(g) ) and otherwise ensuring that advertising and other promotional materials for drugs approved under section 505 of such Act ( 21 U.S.C. 355 ), including pursuant to section 503C of such Act ( 21 U.S.C. 353c ), are not false or misleading, the Secretary of Health and Human Services shall give priority consideration to advertising and other promotional materials for drugs for serious, life-threatening diseases or conditions or substance use disorders, especially opioid drugs and drugs for medication-assisted treatment.
Connectionstraces to 3
Traces to 3 documents
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources